ENHANCING ONCOLOGY INVESTIGATION WITH INTEGRATED KRAS ASSAY COMPANIES AND RAS ASSAYS

while in the swiftly evolving area of oncology investigate, exact and productive mutation screening is important for developing focused therapies. The KRAS companies System performs a pivotal job During this landscape by presenting complete options for KRAS mutation profiling and Assessment. KRAS mutations, located in roughly 95% of RAS-relevant on